ONPH (Oncology Pharma) Asset Turnover: 0.00 (As of Dec. 2004)


What is Oncology Pharma Asset Turnover?

Oncology Pharma ONPH -24.29% Asset Turnover is 0.00 as of Dec. 2004.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Oncology Pharma's Revenue for the three months ended in Dec. 2004 was $0.00 Mil. Oncology Pharma's Total Assets for the quarter that ended in Dec. 2004 was $0.02 Mil. Therefore, Oncology Pharma's Asset Turnover for the quarter that ended in Dec. 2004 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Oncology Pharma's annualized ROE % for the quarter that ended in Dec. 2004 was 79.90%. It is also linked to ROA % through Du Pont Formula. Oncology Pharma's annualized ROA % for the quarter that ended in Dec. 2004 was -1,440.00%.


Oncology Pharma  (OTCPK:ONPH) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Oncology Pharma's annulized ROE % for the quarter that ended in Dec. 2004 is

ROE %**(Q: Dec. 2004 )
=Net Income/Total Stockholders Equity
=-0.324/-0.4055
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.324 / 0)*(0 / 0.0225)*(0.0225/ -0.4055)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.0555
=ROA %*Equity Multiplier
=-1,440.00 %*-0.0555
=79.90 %

Note: The Net Income data used here is four times the quarterly (Dec. 2004) net income data. The Revenue data used here is four times the quarterly (Dec. 2004) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Oncology Pharma's annulized ROA % for the quarter that ended in Dec. 2004 is

ROA %(Q: Dec. 2004 )
=Net Income/Total Assets
=-0.324/0.0225
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.324 / 0)*(0 / 0.0225)
=Net Margin %*Asset Turnover
= %*0
=-1,440.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2004) net income data. The Revenue data used here is four times the quarterly (Dec. 2004) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Oncology Pharma Asset Turnover Related Terms


Oncology Pharma Asset Turnover Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Asset Turnover Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Asset Turnover
Get a 7-Day Free Trial 0.67 0.26 0.68 0.84 1.22

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.25 0.00 0.00 0.00

ONPH vs TAUG, IMUN, TNTY: Asset Turnover Comparison

For the Shell Companies subindustry, Oncology Pharma's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncology Pharma Asset Turnover vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oncology Pharma's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Oncology Pharma's Asset Turnover falls into.



Oncology Pharma Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Oncology Pharma's Asset Turnover for the fiscal year that ended in Mar. 2003 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2003 )/( (Total Assets (A: Mar. 2002 )+Total Assets (A: Mar. 2003 ))/ count )
=3.28/( (3.611+1.751)/ 2 )
=3.28/2.681
=1.22

Oncology Pharma's Asset Turnover for the quarter that ended in Dec. 2004 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2004 )/( (Total Assets (Q: Sep. 2004 )+Total Assets (Q: Dec. 2004 ))/ count )
=0/( (0.002+0.043)/ 2 )
=0/0.0225
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.00 mean?
Oncology Pharma (ONPH) has a Asset Turnover of 0.00 as of Dec. 2004. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Oncology Pharma and its competitors.
Is Oncology Pharma's Asset Turnover too high?
Oncology Pharma's current Asset Turnover is 0.00.
How does Oncology Pharma's Asset Turnover compare to TAUG and IMUN?
Oncology Pharma's Asset Turnover of 0.00 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Diversified Financial Services company?
A good Asset Turnover depends on the Diversified Financial Services industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Oncology Pharma and its competitors. Oncology Pharma's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Asset Turnover is 0.00 as of Dec. 2004. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.